跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 29 条关于
“XinThera”
全部
29
临床试验
3
药物
6
机构
11
资讯
9
上个月
Khartis Therapeutics Emerges from Stealth with $95 Million to Advance First Oral, Selective IGF-1R Inhibitor for Thyroid Eye Disease
5个月前
Panthera Biopartners Expands European Clinical Trial Network with Hungarian Acquisition
去年
Swissmedic Accepts Santhera's Marketing Application for AGAMREE® in Duchenne Muscular Dystrophy
去年
Santhera's Agamree Receives NICE Recommendation and China NMPA Approval for Duchenne Muscular Dystrophy Treatment
去年
Panthera Biopartners Secures £20M in Clinical Trial Contracts Amid UK SMO Sector Growth
去年
Panthera Biopartners Secures Major Investment from LDC to Expand UK's Largest Clinical Trial SMO Network
12个月前
Santhera Secures CHF 20 Million Growth Funding to Accelerate Global AGAMREE Rollout for Duchenne Muscular Dystrophy
8个月前
Santhera Secures Swiss Approval for AGAMREE as Nxera Expands Asia-Pacific Access for Duchenne Muscular Dystrophy Treatment
去年
Enthera Pharmaceuticals Announces Publication in the Journal of Clinical Investigation Supporting the Clinical Development of Ebrasodebart